Rankings
▼
Calendar
CRIS Q2 2018 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena
CRIS
Curis, Inc.
$14M
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
+14.4% YoY
Gross Profit
$2M
94.3% margin
Operating Income
-$8M
-333.3% margin
Net Income
-$9M
-367.4% margin
EPS (Diluted)
$-5.23
QoQ Revenue Growth
-4.5%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$53M
Total Liabilities
$46M
Stockholders' Equity
$7M
Cash & Equivalents
$30M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$2M
+14.4%
Gross Profit
$2M
$2M
+13.2%
Operating Income
-$8M
-$13M
+40.0%
Net Income
-$9M
-$14M
+38.5%
Revenue Segments
Drug Development Royalty
$100,000
100%
← FY 2018
All Quarters
Q3 2018 →